Wireless brain implant could revolutionize epilepsy monitoring
NCT ID NCT05915988
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new wireless device called UNEEG EpiSight, which is implanted under the skin to record brain activity (EEG) continuously for up to 13 months. It involves 19 adults with uncontrolled epilepsy whose seizures can be detected by the implant. The goal is to see if the device works reliably and safely for long-term seizure monitoring, which could help doctors tailor treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
UNEEG EpiSight device (wireless EEG implant placed under the skin)
What this could lead to
If successful, this device could provide a more convenient way to monitor seizures long-term, helping doctors better manage epilepsy.
What could go wrong
This is a small, early-stage study with only 19 participants, so results may not apply to everyone. The device requires surgery and may have risks like infection or discomfort.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aalborg University Hospital
Aalborg, 9000, Denmark
-
Beaumont Hospital
Dublin, 9, Ireland
-
Cork University Hospital
Cork, Ireland
-
Odense University Hospital
Odense, 5000, Denmark
-
Regional Hospital of Viborg
Viborg, 8800, Denmark